Clinical Trial Update: PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating PD and safety of TG-0054 in combination with G-CSF for patients with multiple myeloma and lymphomas; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• TG-0054

Snippet

Sponsor: GPCR Therapeutics, Inc. | Conditions: Multiple Myeloma, Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13